Respiratory Syncytial Virus and US Pediatric Intensive Care Utilization.

ABSTRACT:

Importance

Bronchiolitis is the most common diagnosis necessitating respiratory support and pediatric intensive care, and respiratory syncytial virus (RSV) is the most common cause of bronchiolitis. In 2023, the monoclonal antibody nirsevimab and the maternal RSVpreF vaccine were implemented to prevent RSV in infants.

Objective

To determine the potential association of novel RSV prevention strategies with pediatric intensive care unit (ICU) utilization.

Design, setting, and participants

This retrospective cross-sectional study examined US pediatric ICU encounters with and without RSV from January 1, 2017, to June 1, 2023. Data were from Oracle Cerner RealWorld Data, a national electronic health record database. All children (aged >1 day and <18 years) admitted to an I

SUBMITTER: Shanklin A 

PROVIDER: S-EPMC11581606 | biostudies-literature | 2024 Oct

REPOSITORIES: biostudies-literature